Archive: September 15th, 2022
0
YishengBio received approval from Philippines for phase 2/3 clinical trials of PIKA Recombinant COVID-19 vaccine

MANILA, Philippines - YishengBio Co., Ltd., ("YishengBio"), a biopharmaceutical company dedicated to discovery, development, manufacturing and ...

ASTIG: Philippine News & Reviews
Logo